Navigation Links
Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
Date:3/4/2013

HARTFORD, Conn., March 4, 2013 /PRNewswire/ -- Genomas®, a biomedical company delivering personalized medicine to modern clinical practice, has been awarded clinical laboratory licenses in three of the most populous States. The company's Laboratory of Personalized Health received licenses from the New York Department of Health, the Florida Agency for Health Care Administration, and the California Department of Public Health.

Gualberto Ruano , M.D., Ph.D., President of Genomas and Director of the Laboratory of Personalized Health (LPH) stated: "New York, Florida, and California are among the most demanding States in terms of laboratory technical expertise and business credentialing. Now we are determined to bring our clinical pharmacogenetics services to the people of these States and the entire nation." These key markets herald a national platform for Genomas products in personalized healthcare, medical decision-support and clinical genomic diagnostics.

LPH was certified previously by the Centers for Medicare and Medicaid Services (CMS) under CLIA (Clinical Laboratory Improvement Amendments, and was licensed by the CT Department of Public Health in 2005. In 2012, Genomas had attained credentialing as a Medicare provider and began providing services in Texas and Pennsylvania.

More than 500 clinicians and 5000 patients in Connecticut have already benefited from the Genomas HILOmet PhyzioType® System, which allows personalized management of over 250 drugs to treat mental illness, pain, diabetes, and heart disease. Clinicians access the information through the Personalized Health Portal, which is a secure web-based interface providing data on over 250 different medications. The clinical support extends to 130 neuro-psychiatric drugs (antidepressants, neuroleptics, anticonvulsants, anxiolytics, stimulants, analgesics, hypnotics) and 120 cardio-metabolic drugs (to treat hypertension, diabetes, angina, thrombosis, gastro-esophageal reflux disease, erectile dysfunction, asthma).

In CT, Genomas has established a successful distribution and customer support partnership with Clinical Laboratory Partners (CLP). James Fantus , President and CEO of CLP, and Vice President of Hartford Healthcare Corporation, commented: "It is a great satisfaction to witness a national platform developing through Genomas from Hartford Healthcare partnerships, which include Clinical Laboratory Partners, Hartford Hospital, Institute of Living, and Hospital of Central Connecticut. Genomas is leading Connecticut to national prominence in the clinical practice of personalized medicine."

Please visit www.genomas.com for more information.


'/>"/>
SOURCE Genomas
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology
3. Ansell Limited Expands Korean Presence
4. Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
5. Groundbreaking National Program to Reverse Obesity Expands to 50 Locations
6. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
7. IntelliCell BioSciences Expands Management Team
8. Questcor Pharmaceuticals Expands Repurchase Program
9. CuraLase Expands with New Franchise in Texas
10. BioNeutral Group Expands The Testing Of Its Ygiene Sterilant Against Anthrax Spores
11. Medtech Expands Nursing Education Opportunities In Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):